Triamterene and Hydrochlorothiazide
Triamterene and Hydrochlorothiazide is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Triamterene and Hydrochlorothiazide; Generic name: TRIAMTERENE AND HYDROCHLOROTHIAZIDE; Drug class: Thiazide Diuretic [EPC].
| Brand name | Triamterene and Hydrochlorothiazide |
|---|---|
| Generic name | TRIAMTERENE AND HYDROCHLOROTHIAZIDE |
| Drug class | Thiazide Diuretic [EPC] |
| Manufacturer | Aphena Pharma Solutions - Tennessee, LLC |
| Used for | INDICATIONS AND USAGE This fixed combination drug is not indicated for the initial therapy of edema or hypertension except in individuals in whom the development of hypokalemia cannot be risked. Triamterene and hydrochlorothiazide tablets are indicated for the treatment of hypertension or edema in patients who develop hypokalemia on hydrochlorothiazide alone. Triamterene and hydrochlorothiazide is also indicated for those patients who require a thiazide diuretic and in whom the development of hypokalemia cannot be risked (e.g., patients on concomitant digitalis preparations, or with a history of cardiac arrhythmias, etc.). Triamterene and hydrochlorothiazide may be used alone or in combinati |
| Dosage | DOSAGE AND ADMINISTRATION Note: 37.5 mg/25 mg = 37.5 mg triamterene and 25 mg hydrochlorothiazide 75 mg/50 mg = 75 mg triamterene and 50 mg hydrochlorothiazide The usual dose of Triamterene and Hydrochlorothiazide 37.5 mg/25 mg is one or two tablets daily, given as a single dose, with appropriate monitoring of serum potassium (see WARNINGS ). The usual dose of Triamterene and Hydrochlorothiazide 75 mg/50 mg is one tablet daily, with appropriate monitoring of serum potassium (see WARNINGS ). Ther |
| Warnings | WARNINGS Hyperkalemia Abnormal elevation of serum potassium levels (greater than or equal to 5.5 mEq/liter) can occur with all potassium-conserving diuretic combinations, including triamterene and hydrochlorothiazide. Hyperkalemia is more likely to occur in patients with renal impairment, diabetes (even without evidence of renal impairment), or elderly or severely ill patients. Since uncorrected hyperkalemia may be fatal, serum potassium levels must be monitored at frequent intervals especially |
| Active ingredient(s) | HYDROCHLOROTHIAZIDE |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=15e6f934-fe66-4640-bdf1-13b389cd9e54 |